First Light Asset Management, LLC
- SEC CIK
- 0001600004
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 71
- 0 vs. Q2 2022
- Portfolio value
- $988.1M
- +$128.7M (+15.0%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 1,538,678 | $93.3M | 9.4% | −399,505−20.6% | Reduced | History |
| MODNModel N, Inc. | COM | 2,608,221 | $89.3M | 9.0% | −145,537−5.3% | Reduced | History |
| ATRCAtriCure, Inc. | COM | 1,494,655 | $58.4M | 5.9% | +15,029+1.0% | Added | History |
| SPNESeaSpine Holdings Corp | COM | 7,067,572 | $40.1M | 4.1% | +37,263+0.5% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 166,316 | $37.4M | 3.8% | +40,523+32.2% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 932,244 | $36.9M | 3.7% | −9,001−1.0% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 2,027,963 | $35.4M | 3.6% | +21,659+1.1% | Added | History |
| CUTRCutera Inc | COM | 763,180 | $34.8M | 3.5% | −8,634−1.1% | Reduced | History |
| AXGNAxogen, Inc. | COM | 2,911,824 | $34.7M | 3.5% | −113,295−3.7% | Reduced | History |
| KRYSKrystal Biotech, Inc. | COM | 492,555 | $34.3M | 3.5% | −103,057−17.3% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 349,106 | $30.4M | 3.1% | +2,077+0.6% | Added | History |
| RETAReata Pharmaceuticals Inc | CL A | 1,054,985 | $26.5M | 2.7% | +1,054,985 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,346,652 | $26.4M | 2.7% | +106,043+8.5% | Added | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,974,658 | $26.0M | 2.6% | +49,694+1.7% | Added | History |
| Bellus Health Inc New07987C204 | COM NEW | 2,381,857 | $25.2M | 2.5% | −26,217−1.1% | Reduced | – |
| NEONeogenomics Inc | COM NEW | 2,720,099 | $23.4M | 2.4% | +4,612+0.2% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 485,620 | $23.2M | 2.4% | +18,065+3.9% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 598,213 | $22.5M | 2.3% | −1200.0% | Reduced | History |
| AXNXAxonics, Inc. | COM | 316,809 | $22.3M | 2.3% | +2,805+0.9% | Added | History |
| FNAParagon 28, Inc. | COM | 1,238,055 | $22.1M | 2.2% | +5440.0% | Added | History |
| PLRXPliant Therapeutics, Inc. | COM | 965,114 | $20.2M | 2.0% | +195,744+25.4% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 453,794 | $18.8M | 1.9% | +1,324+0.3% | Added | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 704,721 | $16.4M | 1.7% | +439+0.1% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 756,417 | $16.3M | 1.6% | −5,765−0.8% | Reduced | History |
| KIDSOrthopediatrics Corp | COM | 308,728 | $14.2M | 1.4% | −5,996−1.9% | Reduced | History |
| KRMDKORU Medical Systems, Inc. | COM | 6,273,773 | $14.0M | 1.4% | +170,839+2.8% | Added | History |
| NGMNGM Biopharmaceuticals Inc | COM | 955,505 | $12.5M | 1.3% | −180,379−15.9% | Reduced | History |
| HCATHealth Catalyst, Inc. | COM | 1,149,833 | $11.2M | 1.1% | +14,668+1.3% | Added | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 522,864 | $11.0M | 1.1% | +245,190+88.3% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 123,322 | $10.5M | 1.1% | +18,509+17.7% | Added | History |
| BVSBioventus Inc. | COM CL A | 1,398,922 | $9.79M | 1.0% | +50,462+3.7% | Added | History |
| CDNACareDx, Inc. | COM | 549,797 | $9.36M | 0.9% | −226,823−29.2% | Reduced | History |
| PHLTPerformant Healthcare Inc | COM | 5,020,107 | $9.29M | 0.9% | +3300.0% | Added | History |
| MXCTMaxcyte, Inc. | COM | 1,362,543 | $8.86M | 0.9% | +43,054+3.3% | Added | History |
| PFEPfizer Inc | Stock | 147,151 | $6.44M | 0.7% | +795+0.5% | Added | History |
| AKUAkumin Inc. | COM | 3,764,264 | $6.44M | 0.7% | 00.0% | Unchanged | History |
| TMDXTransMedics Group, Inc. | COM | 153,769 | $6.42M | 0.6% | +153,769 | New | History |
| Direxion Shs ETF Tr25490K323 | SP BIOTCH BL NEW | 857,815 | $6.01M | 0.6% | +857,815 | New | – |
| Abcam PLC000380204 | ADS | 383,557 | $5.75M | 0.6% | +162,719+73.7% | Added | – |
| OPRXOptimizeRx Corp | COM NEW | 364,036 | $5.39M | 0.5% | +3,275+0.9% | Added | History |
| GMABGenmab A/S | SPONSORED ADS | 161,727 | $5.20M | 0.5% | +842+0.5% | Added | History |
| CSTLCastle Biosciences Inc | COM | 163,224 | $4.26M | 0.4% | +163,224 | New | History |
| NARIInari Medical, Inc. | Stock | 45,313 | $3.29M | 0.3% | +284+0.6% | Added | History |
| MIROMiromatrix Medical Inc. | COM | 516,007 | $2.26M | 0.2% | 00.0% | Unchanged | History |
| SLPSimulations Plus, Inc. | COM | 36,061 | $1.75M | 0.2% | −39,924−52.5% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 1,244 | $565.0K | 0.1% | 00.0% | Unchanged | History |
| CICigna Group | Stock | 1,943 | $539.0K | 0.1% | 00.0% | Unchanged | History |
| CVSCVS Health Corp | Stock | 5,519 | $526.0K | 0.1% | 00.0% | Unchanged | History |
| HUMHumana Inc | Stock | 1,068 | $518.0K | 0.1% | 00.0% | Unchanged | History |
| BMYBristol Myers Squibb Co | Stock | 7,256 | $516.0K | 0.1% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 2,466 | $516.0K | 0.1% | 00.0% | Unchanged | History |
| ABBVAbbVie Inc. | Stock | 3,740 | $502.0K | 0.1% | 00.0% | Unchanged | History |
| MCKMcKesson Corp | Stock | 1,346 | $457.0K | <0.1% | 00.0% | Unchanged | History |
| BDXBecton Dickinson & Co | Stock | 1,888 | $421.0K | <0.1% | 00.0% | Unchanged | History |
| GILDGilead Sciences, Inc. | Stock | 6,705 | $414.0K | <0.1% | 00.0% | Unchanged | History |
| WATWaters Corp | COM | 1,536 | $414.0K | <0.1% | 00.0% | Unchanged | History |
| NVSTEnvista Holdings Corp | COM | 11,793 | $387.0K | <0.1% | 00.0% | Unchanged | History |
| HOLXHologic Inc | COM | 5,845 | $377.0K | <0.1% | 00.0% | Unchanged | History |
| ITGRInteger Holdings Corp | COM | 5,846 | $364.0K | <0.1% | 00.0% | Unchanged | History |
| JNJJohnson & Johnson | Stock | 2,161 | $353.0K | <0.1% | 00.0% | Unchanged | History |
| PRGOPERRIGO Co plc | SHS | 9,823 | $350.0K | <0.1% | 00.0% | Unchanged | History |
| NUVANuvasive Inc | COM | 7,850 | $344.0K | <0.1% | 00.0% | Unchanged | History |
| TAKTakeda Pharmaceutical Co Ltd | ADR | 25,630 | $332.0K | <0.1% | 00.0% | Unchanged | History |
| BAXBaxter International Inc | Stock | 5,929 | $319.0K | <0.1% | 00.0% | Unchanged | History |
| ICUIIcu Medical Inc | COM | 2,039 | $307.0K | <0.1% | 00.0% | Unchanged | History |
| GSKGSK plc | ADR | 10,058 | $296.0K | <0.1% | +10,058 | New | History |
| AVTRAvantor, Inc. | COM | 14,596 | $286.0K | <0.1% | 00.0% | Unchanged | History |
| SYNHSyneos Health, Inc. | CL A | 5,736 | $270.0K | <0.1% | 00.0% | Unchanged | History |
| SNYSanofi | SPONSORED ADR | 6,650 | $253.0K | <0.1% | 00.0% | Unchanged | History |
| SONXSonendo, Inc. | COM | 223,393 | $239.0K | <0.1% | +223,393 | New | History |
| HLNHaleon plc | ADR | 12,574 | $77.0K | <0.1% | +12,574 | New | History |
Sold out since Q2 2022 (7)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| TPTXTurning Point Therapeutics, Inc. | COM | 140,801 | $10.6M | 1.2% | History |
| CDXSCodexis, Inc. | COM | 685,213 | $7.17M | 0.8% | History |
| iShares Russell 2000 Growth ETF464287648 | ETF | 13,242 | $2.73M | 0.3% | – |
| LHCGLHC Group, Inc | COM | 15,392 | $2.40M | 0.3% | History |
| SIENProject Sage Oldco, Inc. | COM | 1,431,387 | $1.20M | 0.1% | History |
| GSKGSK plc | SPONSORED ADR | 12,574 | $547.0K | 0.1% | History |
| UHSUniversal Health Services Inc | CL B | 2,050 | $206.0K | <0.1% | History |